Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × defactinib × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Glioblastoma 2 Melanoma 1 Brain Neoplasms 1

Interventions

Radiosurgery 21 Nivolumab 17 Ipilimumab 16 pembrolizumab 15 Temozolomide 10 dabrafenib 8 binimetinib 8 Cyclophosphamide 8 encorafenib 7 trametinib 6 Magnetic Resonance Spectroscopy 6 Bevacizumab 6 fludarabine 5 cobimetinib 5 Specimen Handling 4 fludarabine phosphate 3 aldesleukin 3 Vemurafenib 3 Thalidomide 3 Oxaliplatin 3 Interleukin-2 3 CTLA-4 Antigen 3 tovorafenib 2 pazopanib 2 cediranib 2 Surveys and Questionnaires 2 Spermine Synthase 2 Radiotherapy 2 Radiation 2 Paclitaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06194929 2025-12-03

DETERMINE

University of Utah

Phase 1/2 Recruiting

CNSDermatologic

Brain Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡